Ventyx Biosciences Inc (NASDAQ: VTYX) kicked off on Friday, down -5.29% from the previous trading day, before settling in for the closing price of $9.26. Over the past 52 weeks, VTYX has traded in a range of $0.78-$9.50.
Healthcare Sector giant saw their annual sales slid by -87.13% over the last five years. While this was happening, its average annual earnings per share was recorded 26.51%. With a float of $63.66 million, this company’s outstanding shares have now reached $71.34 million.
Ventyx Biosciences Inc (VTYX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ventyx Biosciences Inc is 10.79%, while institutional ownership is 63.72%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.
Ventyx Biosciences Inc (VTYX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.41 earnings per share (EPS), higher than consensus estimate (set at -0.55) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.88% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Take a look at Ventyx Biosciences Inc’s (VTYX) current performance indicators. Last quarter, stock had a quick ratio of 17.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Analysing the last 5-days average volume posted by the [Ventyx Biosciences Inc, VTYX], we can find that recorded value of 2.88 million was better than the volume posted last year of 2.13 million. As of the previous 9 days, the stock’s Stochastic %D was 85.62%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 90.33%, which indicates a significant increase from 88.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.94 in the past 14 days, which was higher than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.21, while its 200-day Moving Average is $2.48. Now, the first resistance to watch is $9.39. This is followed by the second major resistance level at $10.01. The third major resistance level sits at $10.62. If the price goes on to break the first support level at $8.15, it is likely to go to the next support level at $7.54. Now, if the price goes above the second support level, the third support stands at $6.92.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
The company with the Market Capitalisation of 625.82 million has total of 71,309K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -135,120 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -26,990 K.
